Gustavo A. Angarita, MD, MHS
Assistant Professor of PsychiatryCards
Appointments
Additional Titles
Director, Yale Cocaine Research Clinic, Psychiatry
Inpatient Chief of the Clinical Neuroscience Research Unit (CNRU), Psychiatry
Medical Director, Forensic Drug Diversion Clinic (ForDD)
Contact Info
Appointments
Additional Titles
Director, Yale Cocaine Research Clinic, Psychiatry
Inpatient Chief of the Clinical Neuroscience Research Unit (CNRU), Psychiatry
Medical Director, Forensic Drug Diversion Clinic (ForDD)
Contact Info
Appointments
Additional Titles
Director, Yale Cocaine Research Clinic, Psychiatry
Inpatient Chief of the Clinical Neuroscience Research Unit (CNRU), Psychiatry
Medical Director, Forensic Drug Diversion Clinic (ForDD)
Contact Info
About
Titles
Assistant Professor of Psychiatry
Director, Yale Cocaine Research Clinic, Psychiatry; Inpatient Chief of the Clinical Neuroscience Research Unit (CNRU), Psychiatry; Medical Director, Forensic Drug Diversion Clinic (ForDD)
Biography
Experiencing the impact of the cocaine epidemic in my native Colombia led me to pursue a career dedicated to the improved understanding and treatment of cocaine addiction. Since completing Clinical Training and becoming U.S Board Certified in Adult Psychiatry and Addictions Psychiatry in 2012, I have developed academic interest in the regulation of cocaine self-administration in humans, the validation of Remote Wireless Sensor Network (RWSN) technology for detecting cocaine use, and the role of cocaine-induced deficits in sleep in the putative therapeutic effects of the atypical stimulant, modafinil. Currently; my main career interests lie in the development of neurobiologically informed medication treatments for cocaine dependence, such as the ones based on homeostatic changes on the glutamatergic pathways. As Inpatient Chief of the Clinical Neuroscience Research Unit (CNRU) of the Connecticut Mental Health Center (CMHC), I provide care for the patients who are admitted on our floor in order to participate in research studies or in order to receive treatment for the psychiatric conditions afflicting them. This setting fosters collaboration with other clinicians, researchers, as well as teaching of Medical Students and Psychiatry Residents
Appointments
Psychiatry
Assistant ProfessorPrimary
Other Departments & Organizations
Education & Training
- MHS
- Yale University School of Medicine (2017)
- Clinical and Research Fellow in Addictions Psychiatry
- Harvard Medical School (2012)
- Resident in Adult Psychiatry
- Yale University School of Medicine (2010)
- Research Fellowship in Addictions
- Harvard Medical School (2006)
- MD
- Universidad Militar Nueva Granada (2002)
Research
Research at a Glance
Yale Co-Authors
Publications Timeline
Peter Morgan, MD, PhD
Publications
2016
Domain adaptation methods for improving lab-to-field generalization of cocaine detection using wearable ECG
Natarajan A, Angarita G, Gaiser E, Malison R, Ganesan D, Marlin BM. Domain adaptation methods for improving lab-to-field generalization of cocaine detection using wearable ECG. 2016, 2016: 875-885. PMID: 28090605, PMCID: PMC5235327, DOI: 10.1145/2971648.2971666.Peer-Reviewed Original ResearchCitations
2014
Conditional random fields for morphological analysis of wireless ECG signals
Natarajan A, Gaiser E, Angarita G, Malison R, Ganesan D, Marlin B. Conditional random fields for morphological analysis of wireless ECG signals. 2014, 2014: 370-379. PMID: 26726321, PMCID: PMC4697765, DOI: 10.1145/2649387.2649414.Peer-Reviewed Original ResearchCitationsConceptsECG signalsConditional random field modelOpen-source toolkitConditional Random FieldsMobile sensing technologiesIndependent prediction modelsRandom field modelSensor dataNew computational toolsSensing technologyRandom fieldsComputational toolsNovel approachField modelPrediction modelDiverse applicationsSame featuresNon-stationary signalsLab-based studiesUsersToolkitProblemTechnologyFrameworkCapability
2013
Abstinence-related changes in sleep during treatment for cocaine dependence
Angarita GA, Canavan SV, Forselius E, Bessette A, Pittman B, Morgan PT. Abstinence-related changes in sleep during treatment for cocaine dependence. Drug And Alcohol Dependence 2013, 134: 343-347. PMID: 24315572, PMCID: PMC4396819, DOI: 10.1016/j.drugalcdep.2013.11.007.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsTotal sleep timeExtended abstinenceOutpatient cognitive behavioral therapyAbstinence-related changesDecreased slow wave sleepInpatient substance abuse treatmentCognitive behavioral therapySleep timeCocaine usersPolysomnographic sleepChronic cocaine usersCocaine-dependent participantsSubstance abuse treatmentThrice weekly urine toxicologyBehavioral therapyWeeks of abstinenceOverall sleep qualityAbuse treatmentDays abstinentDependent participantsREM sleep latencySleep qualityCocaine dependenceSlow-wave sleepAbstinence
2009
Regulation of cocaine self-administration in humans: Lack of evidence for loading and maintenance phases
Angarita GA, Pittman B, Gueorguieva R, Kalayasiri R, Lynch WJ, Sughondhabirom A, Morgan PT, Malison RT. Regulation of cocaine self-administration in humans: Lack of evidence for loading and maintenance phases. Pharmacology Biochemistry And Behavior 2009, 95: 51-55. PMID: 20005893, PMCID: PMC2824073, DOI: 10.1016/j.pbb.2009.12.005.Peer-Reviewed Original ResearchCitations
2008
A randomized, double-blind, placebo-controlled trial of long-acting risperidone in cocaine-dependent men.
Loebl T, Angarita GA, Pachas GN, Huang KL, Lee SH, Nino J, Logvinenko T, Culhane MA, Evins AE. A randomized, double-blind, placebo-controlled trial of long-acting risperidone in cocaine-dependent men. The Journal Of Clinical Psychiatry 2008, 69: 480-6. PMID: 18294021, DOI: 10.4088/jcp.v69n0321.Peer-Reviewed Original Research
2007
No-Show for Treatment in Substance Abuse Patients with Comorbid Symptomatology: Validity Results from a Controlled Trial of the ASAM Patient Placement Criteria.
Angarita GA, Reif S, Pirard S, Lee S, Sharon E, Gastfriend DR. No-Show for Treatment in Substance Abuse Patients with Comorbid Symptomatology: Validity Results from a Controlled Trial of the ASAM Patient Placement Criteria. Journal Of Addiction Medicine 2007, 1: 79-87. PMID: 21768939, DOI: 10.1097/ADM.0b013e3180634c1d.Peer-Reviewed Original Research
2005
Prevalence of physical and sexual abuse among substance abuse patients and impact on treatment outcomes.
Pirard S, Sharon E, Kang SK, Angarita GA, Gastfriend DR. Prevalence of physical and sexual abuse among substance abuse patients and impact on treatment outcomes. Drug And Alcohol Dependence 2005, 78: 57-64. PMID: 15769558, DOI: 10.1016/j.drugalcdep.2004.09.005.Peer-Reviewed Original Research
Clinical Trials
Current Trials
A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease (GATEWAY)
HIC ID2000028887RoleSub InvestigatorPrimary Completion Date07/31/2023Recruiting ParticipantsGenderBothAge18 years - 60 yearsBrain Imaging and Synaptic Plasticity
HIC ID2000029552RolePrincipal InvestigatorPrimary Completion Date06/30/2026Recruiting ParticipantsGenderBothAge21 years - 60 yearsEligibility for Participation in Neuroimaging Studies
HIC ID2000027842RoleSub InvestigatorPrimary Completion Date12/31/2023Recruiting ParticipantsHPA axis function in the brains of PTSD, Trauma Exposed, or Otherwise Healthy research participants utilizing PET and MRI imaging
HIC ID2000028748RoleSub InvestigatorPrimary Completion Date08/31/2025Recruiting ParticipantsGenderBothAge18 years - 55 yearsStudying the Adult Brain
HIC ID2000025671RoleSub InvestigatorPrimary Completion Date07/31/2025Recruiting Participants
Clinical Care
Overview
Clinical Specialties
Board Certifications
Addiction Psychiatry
- Certification Organization
- AB of Psychiatry & Neurology
- Original Certification Date
- 2012
Psychiatry
- Certification Organization
- AB of Psychiatry & Neurology
- Original Certification Date
- 2011
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileNews
News
- October 16, 2024Source: Biological Psychiatry
Vitamin D’s Capacity to Increase Amphetamine-Induced Dopamine Release in Healthy Humans: A Clinical Translational [11C]-PHNO Positron Emission Tomography Study
- August 23, 2024
Microglia-Mediated Neuroimmune Suppression in PTSD Is Associated With Anhedonia
- August 13, 2024
Oliva Receives Travel Award to Attend AAAP Annual Meeting
- April 22, 2024
Pulido Saavedra Selected to Receive ASHP Travel Award